Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study

Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers

(2016) Piero Ruscitti et al.   BMC Medicine

Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients

(2016) Paolo Sfriso et al.   CLINICAL RHEUMATOLOGY

A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study

(2016) Antonio Vitale et al.   Frontiers in Pharmacology

Presentation and diagnosis of adult-onset Still’s disease: the implications of current and emerging markers in overcoming the diagnostic challenge

(2015) Serena Colafrancesco et al.   Expert Review of Clinical Immunology

Efficacy of Anakinra in Refractory Adult-Onset Stillʼs Disease

(2015) Francisco Ortiz-Sanjuán et al.   MEDICINE

Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey

(2015) Linda Rossi-Semerano et al.   Orphanet Journal of Rare Diseases

Gene-expression analysis of adult-onset Still’s disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity

(2015) Nanguneri Nirmala et al.   Pediatric Rheumatology

Efficacy and safety of biological agents in adult-onset Still’s disease

(2015) G Cavalli et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Successful Treatment of Refractory Adult-Onset Still Disease With Canakinumab

(2015) Simone Barsotti et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Adult onset Still's disease (AOSD) in the era of biologic therapies: Dichotomous view for cytokine and clinical expressions

(2014) Alexandre Thibault Jacques Maria et al.   AUTOIMMUNITY REVIEWS

Adult-onset Still's disease

(2014) Mathieu Gerfaud-Valentin et al.   AUTOIMMUNITY REVIEWS

Canakinumab in a case of Adult onset Still's disease: Efficacy only on systemic manifestations

(2014) Alberto Lo Gullo et al.   JOINT BONE SPINE

Interleukin 18: A Biomarker for Differential Diagnosis Between Adult-onset Still's Disease and Sepsis

(2014) R. Priori et al.   JOURNAL OF RHEUMATOLOGY

Adult-Onset Still Disease

(2014) Mathieu Gerfaud-Valentin et al.   MEDICINE

Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety

(2014) Xingguo Zhang et al.   Drug Design Development and Therapy

Treatment of adult-onset Still’s disease: a review

(2014) Pascal Sève et al.   Therapeutics and Clinical Risk Management

Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still's Disease. An Open, Randomized, Multicenter Study

(2012) D. NORDSTROM et al.   JOURNAL OF RHEUMATOLOGY

The Use of Canakinumab, a Novel IL-1β Long-Acting Inhibitor, in Refractory Adult-Onset Still's Disease

(2012) Apostolos Kontzias et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Anakinra in Adult-Onset Still's Disease: Long-Term Treatment in Patients Resistant to Conventional Therapy

(2012) Cecilia Giampietro et al.   ARTHRITIS CARE & RESEARCH

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

(2011) C. A. Dinarello   BLOOD

Therapeutic responses and prognosis in adult-onset Still’s disease

(2011) Hyoun-Ah Kim et al.   RHEUMATOLOGY INTERNATIONAL

Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study

(2011) Katerina Laskari et al.   ARTHRITIS RESEARCH & THERAPY

Clinical Manifestations but not Cytokine Profiles Differentiate Adult-onset Still's Disease and Sepsis

(2010) M. RAU et al.   JOURNAL OF RHEUMATOLOGY

Interleukin-1 (IL-1) Pathway

(2010) A. Weber et al.   Science Signaling